synthetic peptide comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-04-15. Numbers and descriptions here follow the published literature rather than marketing material.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
| Property | Value | Notes |
|---|---|---|
| Primary research area | Obesity and metabolic regulation | Studied in cell, animal, and human models |
| Highest reported trial phase | Phase II | Public summaries describe mixed results |
| Common route in trials | Subcutaneous injection | Typical for peptide therapeutics |
| Regulatory example | 2013 Australian anti-doping review | Classification was debated at the time |
| Approval status | Not approved as a human medicine | Status can change by jurisdiction |
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
===== MeSH D08.811.277.087 – amidohydrolases ===== MeSH D08.811.277.087.030 – N-acetylmuramoyl-L-alanine amidase MeSH D08.811.277.087.060 – allophanate hydrolase MeSH D08.811.277.087.100 – arylformamidase MeSH D08.811.277.087.116 – asparaginase MeSH D08.811.277.087.125 – aspartylglucosylaminase MeSH D08.811.277.087.180 – beta-lactamases MeSH D08.811.277.087.180.229 – cephalosporinase MeSH D08.811.277.087.180.697 – penicillinase MeSH D08.811.277.087.200 – biotinidase MeSH D08.811.277.087.280 – dihydroorotase MeSH D08.811.277.087.483 – glutaminase MeSH D08.811.277.087.520 – histone deacetylases MeSH D08.811.277.087.610 – nicotinamidase MeSH D08.811.277.087.690 – penicillin amidase MeSH D08.811.277.087.725 – peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase MeSH D08.811.277.087.760 – pyroglutamate hydrolase MeSH D08.811.277.087.831 – sirtuins MeSH D08.811.277.087.902 – urease
Nuclear magnetic resonance spectroscopy of proteins (usually abbreviated protein NMR) is a field of structural biology in which NMR spectroscopy is used to obtain information about the structure and dynamics of proteins, and also nucleic acids, and their complexes. The field was pioneered by Richard R. Ernst and Kurt Wüthrich at the ETH, and by Ad Bax, Marius Clore, Angela Gronenborn at the NIH, and Gerhard Wagner at Harvard University, among others. Structure determination by NMR spectroscopy usually consists of several phases, each using a separate set of highly specialized techniques. The sample is prepared, measurements are made, interpretive approaches are applied, and a structure is calculated and validated. NMR involves the quantum-mechanical properties of the central core ("nucleus") of the atom. These properties depend on the local molecular environment, and their measurement provides a map of how the atoms are linked chemically, how close they are in space, and how rapidly they move with respect to each other. These properties are fundamentally the same as those used in the more familiar magnetic resonance imaging (MRI), but the molecular applications use a somewhat different approach, appropriate to the change of scale from millimeters (of interest to radiologists) to nanometers (bonded atoms are typically a fraction of a nanometer apart), a factor of a million. This change of scale requires much higher sensitivity of detection and stability for long term measurement.
He beat Andrey Rublev for the 17th title of his career and the fourth of the season, in 59 minutes, the shortest match in the tournament history. At the US Open, Zverev sought to claim his first major title following his run to the final the previous year. He reached the semifinals following wins over Jack Sock and Lloyd Harris. There, he lost to Novak Djokovic in five sets despite taking the first set, ending his career-high 16-match win streak stretching back to the Olympics. Zverev was seeded 3rd at the 2021 BNP Paribas Open, where he reached the quarterfinals. On the way, he defeated Jenson Brooksby, Andy Murray and Gaël Monfils. He lost to Taylor Fritz, despite having two match points. At the Erste Bank Open in Vienna, seeded second, he defeated Filip Krajinović and Alex de Minaur to reach the quarterfinals. The victory over De Minaur gave Zverev his 300th ATP tour match win. He then beat Félix Auger-Aliassime and Carlos Alcaraz to reach the final where he won his fifth title of the year and 18th overall, defeating Frances Tiafoe in straight sets. Zverev was the fourth seed at the 2021 Rolex Paris Masters. He received a bye into the second round, where he defeated Dušan Lajović. He defeated next sixteenth seed Grigor Dimitrov in the third round and sixth seed Casper Ruud in the quarterfinals. He lost in the semifinals to second seed Daniil Medvedev in straight sets. As a result of this run he equaled his singles career-high ranking of World No. 3 on 8 November 2021. For a fifth successive season, Zverev qualified for the 2021 ATP Finals in Turin, as the third seed.
The influx of refugees troubled the Cossacks, not only because of the increased demand for food but also because their large number meant the Cossacks could not absorb them into their culture by way of the traditional apprenticeship. Instead of taking these steps for proper assimilation into Cossack society, the runaway peasants spontaneously declared themselves Cossacks and lived alongside the true Cossacks, laboring or working as barge-haulers to earn food. Divisions among the Cossacks began to emerge as conditions worsened and Mikhail's son Alexis took the throne. Older Cossacks began to settle and become prosperous, enjoying privileges earned through obeying and assisting the Muscovite system. The old Cossacks started giving up the traditions and liberties that had been worth dying for, to obtain the pleasures of an elite life. The lawless and restless runaway peasants who called themselves Cossacks looked for adventure and revenge against the nobility that had caused them suffering. These Cossacks did not receive the government subsidies that the old Cossacks enjoyed, and had to work harder and longer for food and money.
Magnesium is often used to ignite thermite or other materials that require a high ignition temperature. Magnesium continues to be used as an incendiary element in warfare. Flame temperatures of magnesium and magnesium alloys can reach 3,100 °C (5,610 °F), although flame height above the burning metal is usually less than 300 mm (12 in). Once ignited, such fires are difficult to extinguish because they resist several substances commonly used to put out fires; combustion continues in nitrogen (forming magnesium nitride), in carbon dioxide (forming magnesium oxide and carbon), and in water (forming magnesium oxide and hydrogen, which also combusts due to heat in the presence of additional oxygen).
Sources: en.wikipedia.org
In vitro studies indicate gepotidacin can inhibit specific drug transporters, but the clinical significance of these findings requires further evaluation. Excretion is mainly fecal (~52%, 30% unchanged) and urinary (~31%, 20% unchanged), with the latter being the major route for absorbed drug. Renal impairment leads to elevated gepotidacin exposure, with the degree of increase directly linked to the severity of kidney dysfunction. This effect is particularly pronounced in patients with end-stage renal disease undergoing hemodialysis. Additionally, impaired kidney function decreases urinary excretion of the drug, which may necessitate dosage adjustments in severe cases to ensure safe and effective treatment. Severe hepatic impairment also elevates gepotidacin exposure, while moderate hepatic impairment did not show a clinically relevant effect during clinical trials.
The sarcoplasmic reticulum has a large calcium buffering capacity partially due to a calcium-binding protein called calsequestrin. The near synchronous activation of thousands of calcium sparks by the action potential causes a cell-wide increase in calcium giving rise to the upstroke of the calcium transient. The Ca2+ released into the cytosol binds to Troponin C by the actin filaments, to allow crossbridge cycling, producing force and, in some situations, motion. The sarco/endoplasmic reticulum calcium-ATPase (SERCA) actively pumps Ca2+ back into the sarcoplasmic reticulum. As Ca2+ declines back to resting levels, the force declines and relaxation occurs.
=== Lipid separation === The simplest method of lipid separation is the use of thin layer chromatography (TLC). Although not as sensitive as other methods of lipid detection, it offers a rapid and comprehensive screening tool prior to more sensitive and sophisticated techniques. Solid-phase extraction (SPE) chromatography is useful for rapid, preparative separation of crude lipid mixtures into different lipid classes. This involves the use of prepacked columns containing silica or other stationary phases to separate glycerophospholipids, fatty acids, cholesteryl esters, glycerolipids, and sterols from crude lipid mixtures. High-performance liquid chromatography (HPLC or LC) is extensively used in lipidomic analysis to separate lipids prior to mass analysis. Separation can be achieved by either normal-phase (NP) HPLC or reverse-phase (RP) HPLC. For example, NP-HPLC effectively separates glycerophospholipids on the basis of headgroup polarity, whereas RP-HPLC effectively separates fatty acids such as eicosanoids on the basis of chain length, degree of unsaturation and substitution. For global, untargeted lipidomic studies it is common to use both RP and NP or Hydrophilic Interaction Liquid Chromatrography (HILC) columns for increased lipidome coverage. The application of nano-flow liquid chromatography (nLC) proved thereby to be most efficient to enhance both general measurement sensitivity and lipidome coverage for a global lipidomics approach.
== Acceptance Speech for the Peace Prize of the German Book Trade (2015) == Kermani’s moving acceptance speech, Über die Grenzen – Jacques Mourad und die Liebe in Syrien [Across/AboutBorders — Jacques Mourad and Love in Syria] was widely received and became the subject of heated debate. He dedicated his speech, given at Frankfurt’s Paulskirche, to the Christian priest Jacques Mourad, who feels a connection to Islam. Mouradwas abducted from the Mar Elian monastery in Syria by terrorists of the so-called Islamic State and was later freed by Muslims. Islam and Christianity, religious traditions that appear to be bitterly opposed can also signify the transcendence ofboundaries. Kermani focused his speech on the beauty and spiritual depth of Islam, as well as on terrorism committed in the name of Islam. He also addressed the West’s failings in its dealings with countries such as Saudi Arabia. In this context, Kemani lamented the lack of public discourse on these issues in Germany. He concluded his speech with a prayer for the priests, for the Christians in Syria, and for freedom in the countries of the Middle East.
Sources: en.wikipedia.org
{\displaystyle {\begin{aligned}{\frac {dS}{dt}}&=\Lambda -\mu S-{\frac {\beta IS}{N}}\\[8pt]{\frac {dI}{dt}}&={\frac {\beta IS}{N}}-\gamma I-\mu I\\[8pt]{\frac {dR}{dt}}&=\gamma I-\mu R\end{aligned}}}
=== August === 1 August: The second Donald Trump administration raises tariffs on New Zealand exports to the United States to 15 percent. Visual effects company Wētā FX proposes laying off 100 jobs in its support departments based in Wellington. 4 August: The New Zealand Government announces plans to scrap the National Certificate of Educational Achievement (NCEA) secondary school qualification. A name suppression order lapses for former Deputy Commissioner of Police Jevon McSkimming, who was charged in June 2025 with eight counts of possessing objectionable material including child sexual exploitation and bestiality over a four-year period. 5–6 August — An RNZAF C-130J Hercules evacuated three personnel of the United States National Science Foundation from McMurdo Station. 6 August: The Christchurch-based wool factory Wild Earth Yarns acquires the woollen dye house and spinning mill of the liquidated Napier-based company Design Spun. Hato Hone St John proposes scrapping various community voluntary programmes including hospital volunteers, community carers and pet therapy services as part of a review of its services; affecting about 1,100 people. 8 August – The Japanese Navy makes a stop-over in Wellington for the first time since 1936. 9–10 August – Prime Minister Luxon hosts Australian Prime Minister Anthony Albanese in Queenstown for annual bilateral head of government talks. 10 August — Gloriavale Christian Community's Overseeing Shepherd Howard Temple resigns after pleading guilty to 12 charges of sexual offending against women and girls last month.
Hyperpolarization A change in a cell’s membrane potential that makes it more negative, decreasing the likelihood of firing an action potential. Hypoglossal nerve (Cranial Nerve XII) A cranial nerve responsible for controlling the muscles of the tongue. Damage can cause slurred speech and difficulty swallowing. Hypothalamus A region of the brain below the thalamus that regulates homeostatic functions such as hunger, thirst, body temperature, and circadian rhythms. It controls the pituitary gland and links the nervous and endocrine systems.
=== In adults === While there are some similarities between adults and children, OSA does not have the same consequences in both populations. Examples of similarities are the snoring – which is the most common complaint in both pediatric OSA and OSA in adults – variability of blood pressure and cardiovascular morbidities. A major difference is the excessive daytime sleepiness (EDS) which is commonly reported in adult OSA, while it is not very common in pediatric OSA. Nevertheless, OSA in adults also implies a large scope of adverse and serious consequences, the latter leading to higher mortality amongst OSA patients. Those consequences are even worsened by common morbidities such as obesity.
In mammals, when a muscle contracts, a series of reactions occur. Muscle contraction is stimulated by the motor neuron sending a message to the muscles from the somatic nervous system. Depolarization of the motor neuron results in neurotransmitters being released from the nerve terminal. The space between the nerve terminal and the muscle cell is called the neuromuscular junction. These neurotransmitters diffuse across the synapse and bind to specific receptor sites on the cell membrane of the muscle fiber. When enough receptors are stimulated, an action potential is generated and the permeability of the sarcolemma is altered. This process is known as initiation.
Sources: en.wikipedia.org
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.
It became prominent during a 2013 Australian sports investigation that examined whether it was a prohibited growth-hormone-related substance. Subsequent interpretations and list updates have varied, so current rules should be checked directly.
Published summaries generally report limited or inconsistent weight-loss effects, and complete trial data are not widely available. The studies were not sufficient to establish it as an effective obesity treatment.
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.